CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 107 filers reported holding CULLINAN ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 2.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,161,510 | +4.2% | 2,890,775 | +23.9% | 0.01% | +8.3% |
| Q2 2023 | $25,114,766 | +211.1% | 2,334,086 | +195.8% | 0.01% | +200.0% |
| Q1 2023 | $8,072,880 | -2.2% | 789,138 | +0.9% | 0.00% | 0.0% |
| Q4 2022 | $8,251,429 | -18.0% | 782,126 | -0.4% | 0.00% | -20.0% |
| Q3 2022 | $10,067,000 | +0.8% | 785,219 | +0.8% | 0.01% | 0.0% |
| Q2 2022 | $9,988,000 | +22.6% | 779,082 | +0.2% | 0.01% | +66.7% |
| Q1 2022 | $8,144,000 | -31.9% | 777,880 | +0.4% | 0.00% | -25.0% |
| Q4 2021 | $11,951,000 | -31.8% | 774,534 | -0.2% | 0.00% | -42.9% |
| Q3 2021 | $17,524,000 | -12.5% | 776,406 | -0.1% | 0.01% | -12.5% |
| Q2 2021 | $20,021,000 | -1.6% | 777,498 | +59.2% | 0.01% | 0.0% |
| Q1 2021 | $20,348,000 | – | 488,308 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $118,013,000 | 21.52% |
| CHI Advisors LLC | 2,476,720 | $38,215,000 | 12.68% |
| Nextech Invest Ltd. | 1,221,145 | $18,842,000 | 4.96% |
| Foresite Capital Management V, LLC | 1,143,006 | $17,637,000 | 4.33% |
| Foresite Capital Opportunity Management V, LLC | 381,002 | $5,879,000 | 3.94% |
| BVF INC/IL | 5,369,459 | $82,851,000 | 3.01% |
| Boxer Capital, LLC | 1,074,082 | $16,573,000 | 0.64% |
| Logos Global Management LP | 288,458 | $4,450,000 | 0.46% |
| Birchview Capital, LP | 45,114 | $696,000 | 0.45% |
| Eventide Asset Management | 1,440,145 | $21,665,000 | 0.28% |